A detailed history of Geode Capital Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,287,087 shares of PLRX stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,287,087
Previous 1,214,883 5.94%
Holding current value
$14.4 Million
Previous $18.1 Million 23.56%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$10.58 - $15.61 $763,918 - $1.13 Million
72,204 Added 5.94%
1,287,087 $13.8 Million
Q1 2024

May 13, 2024

BUY
$14.14 - $19.59 $391,465 - $542,349
27,685 Added 2.33%
1,214,883 $18.1 Million
Q4 2023

Feb 13, 2024

BUY
$12.85 - $19.15 $783,644 - $1.17 Million
60,984 Added 5.41%
1,187,198 $21.5 Million
Q3 2023

Nov 13, 2023

BUY
$14.58 - $20.15 $2.01 Million - $2.78 Million
137,742 Added 13.93%
1,126,214 $19.5 Million
Q2 2023

Aug 11, 2023

BUY
$18.12 - $30.56 $10.1 Million - $17.1 Million
558,253 Added 129.76%
988,472 $17.9 Million
Q1 2023

May 15, 2023

BUY
$18.73 - $36.26 $1.51 Million - $2.92 Million
80,611 Added 23.06%
430,219 $11.4 Million
Q4 2022

Feb 13, 2023

BUY
$17.0 - $25.43 $369,580 - $552,848
21,740 Added 6.63%
349,608 $6.76 Million
Q3 2022

Nov 14, 2022

BUY
$7.67 - $24.23 $819,807 - $2.59 Million
106,885 Added 48.37%
327,868 $6.85 Million
Q2 2022

Aug 12, 2022

SELL
$4.11 - $8.75 $759,659 - $1.62 Million
-184,832 Reduced 45.55%
220,983 $1.77 Million
Q1 2022

May 13, 2022

BUY
$7.01 - $14.1 $42,908 - $86,306
6,121 Added 1.53%
405,815 $2.84 Million
Q4 2021

Feb 11, 2022

BUY
$12.27 - $18.26 $972,274 - $1.45 Million
79,240 Added 24.73%
399,694 $5.4 Million
Q3 2021

Nov 12, 2021

BUY
$16.48 - $28.98 $636,095 - $1.12 Million
38,598 Added 13.69%
320,454 $5.41 Million
Q2 2021

Aug 13, 2021

SELL
$28.05 - $37.69 $7,741 - $10,402
-276 Reduced 0.1%
281,856 $8.21 Million
Q1 2021

May 12, 2021

BUY
$24.52 - $40.23 $3.27 Million - $5.36 Million
133,331 Added 89.6%
282,132 $11.1 Million
Q4 2020

Feb 12, 2021

BUY
$19.89 - $32.99 $273,069 - $452,919
13,729 Added 10.16%
148,801 $3.38 Million
Q3 2020

Nov 13, 2020

BUY
$21.54 - $29.53 $2.51 Million - $3.44 Million
116,579 Added 630.4%
135,072 $3.06 Million
Q2 2020

Aug 13, 2020

BUY
$21.3 - $35.26 $393,900 - $652,063
18,493 New
18,493 $600,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $546M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.